Filter by vocabulary: issues (multisite):

By Dr. Unni Karunakara, incoming president of MSF's International Council, and Dr. Bernard Pecoul, executive director of the Drugs for Neglected Diseases initiative

More >

By Dr. Rony Brauman, is the former President of MSF in France and is currently a Research Director at CRASH, MSF's center for reflection on humnaitarian action.

More >

By Jeanne Cabeza,  MSF medical coordinator in Haiti, and Michelle Chouinard, MSF head of mission in Haiti

More >

by Rony BRAUMAN Former president of MSF-France Associate Professor at the Institute of Political Studies in Paris

More >

By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders

More >

By Susan Shepherd The New York Times

More >

The public sector has a key role in drug R&D. Patenting minor changes to extend monopoly prices spells misuse By Dr. Brian Druker

More >

By Dr. Tido von Schoen-Angerer Executive director Access to Essential Medicines Campaign Doctors Without Borders

More >

Dr. Buddhima Lokuge U.S. manager, Access to Essential Medicines Campaign

More >

By David Wilson Medical Coordinator, Doctors Without Borders/Médecins Sans Frontieres

More >

Pages